Accuray: TomoTherapy System Helps Preserve Breast Cancer Patients' Heart And Lung Functionality
WASHINGTON (dpa-AFX) - Accuray Inc. (ARAY) said Thursday that data from a phase III, randomized controlled trial, TomoBreast, indicated post-surgery hypofractionated radiotherapy delivered with